Morgan Stanley maintains Arthur J. Gallagher at Overweight, raises price target to $325 from $295

Morgan Stanley kept its Overweight rating on Arthur J. Gallagher and increased its price target to $325 from $295, suggesting a 14.9% upside from the Nov 13 close of $282.94. Recent analyst price targets for the company range from $300 to $320.

Original reporting
Published Nov 16, 2026, 2:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 3:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains Arthur J. Gallagher at Overweight, raises price target to $325 from $295 — source image
Decision brief

The 30-second read

$AJGBullishLow
01

Why it matters

The price target increase may prompt short-term buying pressure but limited without earnings news.

02

Market read

Analyst rating change provides modest trading signal for AJG.

03

What to watch

No new earnings data; price move may be muted.

Relevance 5/10Novelty 5/10Timing: same-day release

Background

Arthur J. Gallagher is a U.S. insurance brokerage firm; analyst coverage influences investor sentiment.

Company-level read

Ticker impact

$AJGBullishHigh confidence
Context

Morgan Stanley raised its price target on Arthur J. Gallagher to $325, up 10.2% from $295.

Expected impact

likely modest upside as investors price in higher target

Evidence & confidence

Target increase signals improved outlook; no immediate catalyst beyond the rating change.

Market effects

May lift broader insurance brokerage sector modestly.

U.S. market focus; limited regional effect.

Low global relevance.

Counterpoint

Target raise could be premature if underlying earnings miss expectations.

Key entities

  • Morgan Stanley

    Equity research firm raising AJG target.

Related articles

$AJGMed

Why is Arthur J Gallagher stock sliding today?

Arthur J. Gallagher & Co. (AJG) stock fell 0.7% in pre-market trading after BMO Capital and Citi downgraded it to Market Perform and Neutral, respectively, citing valuation concerns. Both firms raised their price targets, with Citi setting it at $300. The stock trades near its 52-week high of $281.53. Insider selling and a risk-averse market also contributed to the decline. Jefferies and Wells Fargo maintained bullish outlooks with higher targets.

$AJGMed

BMO downgrades Arthur J. Gallagher stock rating on valuation

BMO downgraded Arthur J. Gallagher (NYSE:AJG) to Market Perform, raising its price target to $295. The firm cited valuation and AI-related market pressures. AJG's Q3 2026 earnings showed a revenue miss but a 25% net earnings growth. Analysts from Goldman Sachs and Keefe, Bruyette & Woods maintained positive outlooks with targets of $296 and $275, respectively.

$AJGMedAI 8/10

Arthur J. Gallagher & Co (AJG) (Q3 2026) Earnings Call Highlights: 26 Straight Quarters

Arthur J. Gallagher & Co reported Q3 2026 revenue growth of 18%, with net earnings and adjusted EBITDAC up 25%. Brokerage revenues rose 19%, while Risk Management grew 14%. M&A pipeline includes 30 term sheets for $300M in annualized revenue. Challenges include property premium declines and slower Employee Benefits growth. Management expects steady margin expansion and synergies from AssuredPartners.

$AJGMed

Goldman Sachs reiterates Arthur J. Gallagher stock rating on in-line Q3 results

Goldman Sachs maintained a Buy rating and $296 price target on Arthur J. Gallagher (AJG) after Q3 results. Adjusted EPS matched estimates at $3.00, but revenue missed expectations. Goldman lowered 2027 Brokerage growth estimate to 4.5% and adjusted revenue expectations. AJG's stock trades near its 52-week high with a P/E ratio of 44.58. Keefe, Bruyette & Woods raised its price target to $275, citing higher adjusted EBITDAC margins.

$AJGMed

Gallagher’s 5% organic growth looks modest - until you compare it with the competition

Arthur J. Gallagher & Co. reported 5% organic growth in Q3, with revenues of $3.93B and adjusted EPS of $3.00. CEO J. Patrick Gallagher Jr. highlighted the strength of their diversified model. Compared to peers, Gallagher's growth appears modest, but its focus on broking may be advantageous in a softening market. The company completed five acquisitions in Q3, adding $102M in annualized revenues.